Prof docs monthly update - January 2025

Under development/review

• PG18 Guideline on monitoring during anaesthesia (under review)
• PG56 Guideline on equipment to manage difficult airways (under review)
• PG48 Advice on management of substance use disorder in all medical practitioners in anaesthesia and pain management (under development)
• PG28(A) Guideline on infection control in anaesthesia (under review)
• PG46(POM) Guideline on training and practice of perioperative cardiac ultrasound in adults (under review)
• PG44 Guideline on advice for retraining or further training in anaesthesia and pain medicine (under development)
• PG69 Guideline on perioperative anaphylaxis management (under development)
• (PM) Scope of clinical practice for specialist pain medicine physicians (under development)
• (PM) Statement on provision of pain medicine care to children and adolescents (under development)
• PS10(PM) Statement on "Medicinal Cannabis" with particular reference to its use in the management of patients with chronic non-cancer pain (under review)

Stakeholder consultation* 

• PS02 Position statement on credentialling and defining the scope of clinical practice in anaesthesia
• PS45 Position statement on patients' rights to pain management and associated responsibilities 

*Revised documents will be published on the ANZCA website when approved for PILOT. 

Pilot

• PG47 Guideline on training and practice of perioperative point-of-care ultrasound (POCUS) and PG47BP (ends April 2025)
• PS15(PM) Statement on the clinical approach to persistent pelvic pain including endometriosis-associated pain and PS15(PM)BP (ends January 2025)
• PG52 Guideline for transport of critically ill patients and PG52BP (ends January 2025)

We encourage feedback on all professional documents during the pilot phase. If you have any comments or queries regarding professional documents please email us.

Expressions of interest

We’re looking for FPM fellows to help contribute to:

• The development of a new document that will articulate the minimum standards for multidisciplinary pain programs including the role of SPMPs.
• Help review PS12(PM) Position statement on the use of ketamine in the management of chronic non-cancer pain.

 
Contact the faculty for more information.